loading...

Norfolk Quality of Life Questionnaire - Diabetic Neuropathy (Norfolk QOL-DN)

Barlow P; Vinik AI; Vinik EJ

ProQolid

Basic description

Authors

Barlow P; Vinik AI; Vinik EJ

Copyright
Eastern Virginia Medical School, 2003
Objective
To measure patients' perceptions of the effects of diabetic neuropathy (DN)
Therapeutic area
  • Nervous System Diseases
  • Endocrine System Diseases
Therapeutic indication

Diabetic Neuropathies

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Translations
19 translation(s)
Bibliographic reference(s) of the original questionnaire

Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, Vinik AI. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther. 2005 Jun;7(3):497-508 (PubMed abstract)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us